sovleplenib

wAIHA | Sovleplenib Demonstrates Positive Phase III Clinical Results

  wAIHA is a rare autoimmune disorder in which the immune system produces antibodies that mistakenly target and destroy red blood cells, leading to anemia and significant clinical burden. The…

Read More »